Tower Research Capital »

First Tracks Biotherapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $15k 746 20.12

More positions owned by Tower Research Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Apple (AAPL)
Spdr Series Trust St Inter Bd Etf (SPIB)
Micron Technology (MU)
Direxion Shares Etf Trust Dai Sem Bul Etf (SOXL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Intel Corporation (INTC)
Ishares Tr 0-3 Mth Treasury (SGOV)
Alphabet Inc Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Tower Research Capital

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics